Key Insights

Highlights

Treatment Research

3 treatments under study, led by Tak137 5 Mg Tablet Tak137 Placebo Tablet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02322606Phase 1WithdrawnPrimary

A Phase 1, Single and Multiple Dose Study of TAK-137

Showing all 1 trials

Research Network

Common Treatments

  • Tak137 5 Mg Tablet Tak137 Placebo Tablet1
  • Tak137 5mg Tablet Tak137 Placebo Tablet1
  • Tak137 5 Mg Tablet Tak137 Placebo Tablet Or Tak137 05 Mg Tablet Tak137 Placebo Tablet1

Active Sponsors

  • Takeda1

Top Investigators

Activity Timeline